Compare AVNT & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNT | STVN |
|---|---|---|
| Founded | 1927 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2000 | 2021 |
| Metric | AVNT | STVN |
|---|---|---|
| Price | $37.48 | $16.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $41.50 | $25.67 |
| AVG Volume (30 Days) | 527.0K | ★ 629.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.97% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $3,835,500,000.00 | N/A |
| Revenue This Year | $4.90 | $9.67 |
| Revenue Next Year | $3.48 | $9.99 |
| P/E Ratio | $41.52 | ★ $27.15 |
| Revenue Growth | ★ 1.71 | N/A |
| 52 Week Low | $27.48 | $12.89 |
| 52 Week High | $44.85 | $28.00 |
| Indicator | AVNT | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 63.37 |
| Support Level | $35.07 | $13.58 |
| Resistance Level | $38.10 | $16.69 |
| Average True Range (ATR) | 1.01 | 0.75 |
| MACD | 0.07 | 0.29 |
| Stochastic Oscillator | 65.26 | 69.28 |
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.